Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Favipiravir

Back to the Drawing Board for Fujifilm Holdings’ Favipiravir in Japan as it Must Now Execute Another Phase 3 Clinical Trial

Japanese drug regulatory authorities failed to make a decision on whether favipiravir (Avigan) would be used as a treatment for […]

Back to the Drawing Board for Fujifilm Holdings’ Favipiravir in Japan as it Must Now Execute Another Phase 3 Cliicial Trial
1 week ago
Share

NHS Greater Glasgow and Clyde Investigating Favipiravir as Early Onset Treatment for Mild to Moderate COVID-19 in Scotland

Scotland has kicked off a favipiravir-based study investigating the efficacy and safety of that antiviral drug targeting COVID-19 cases in […]

NHS Greater Glasgow and Clyde Investigating Favipiravir as Early Onset Treatment for Mild to Moderate COVID-19 in Scotland
2 weeks ago
Share

Rwanda Accepts Favipiravir for Early Onset Mild COVID-19 Adding to a Growing List of Nations

The eastern African nation of Rwanda appears to be joining dozens of others nations worldwide and accepting Favipiravir as a […]

Rwanda Accepts Favipiravir for Early Onset Mild COVID-19 Adding to a Growing List of Nations`
3 weeks ago
Share

Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19

Appili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious […]

Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19
3 weeks ago
Share

Favipiravir Fails to Help Moderate to Severe Hospitalized COVID-19 Cases However May Lead to Modest Reduction in Duration of Hospitalization

A Kuwait-based clinical trial sponsored by Indian generic drug producer Dr. Reddy’s Laboratory was recently terminated as the resulting data […]

Favipiravir Fails to Help Moderate to Severe Hospitalized COVID-19 Cases However May Lead to Modest Reduction in Duration of Hospitalization
1 month ago
Share

Malaysian National Health Ministry Plans Clinical Trial to Evaluate Ivermectin & Favipiravir as a Low-Cost, Orally Administrated Treatment for COVID-19

The Southeastern nation of Malaysia recently announced the planning for a major clinical trial to evaluate two low cost, widely […]

Malaysian National Health Ministry Plans Clinical Trial to Evaluate Ivermectin & Favipiravir as a Low-Cost, Orally Administrated Treatment for COVID-19
1 month ago
Share

Rwanda Yet Another Country to Accept Favipiravir as a Repurposed Oral Treatment for COVID-19

Yet another nation has opted to embrace the antiviral drug Favipiravir (Avigan) as a treatment for early onset COVID-19.  Approved […]

Rwanda Yet Another Country to Accept Favipiravir as a Repurposed Oral Treatment for COVID-19
1 month ago
Share

Favipiravir for COVID-19: Results Mixed and Research Ongoing

On January 6, The Lancet’s EBIoMedicine published a commentary on the use of Favipiravir for flu and COVID-19. They note […]

Favipiravir for COVID-19: Results Mixed and Research Ongoing
2 months ago
Share

COVID-19 Cases “Drastically’ Dropping in India Leading to Glut of Antivirals Remdesivir & Favipiravir

With the COVID-19 pandemic conditions improving in India according to some local reports, the demand for antiviral drugs Remdesivir and […]

COVID-19 Cases “Drastically’ Dropping in India Leading to Glut of Antivirals Remdesivir & Favipiravir
2 months ago
Share

University of Cincinnati Study Raises Questions Associated with Use of Remdesivir in COVID-19 Patients

A growing number of articles, papers and discussions point out that despite the great news of vaccines approved for emergency […]

Movement in Canada Grows for COVID-19 Therapies as Nation Awaits Health Canada Decision on Favipiravir
2 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.